
Bioorganic and Medicinal Chemistry Letters p. 2001 - 2005 (2002)
Update date:2022-09-26
Topics:
Inguimbert, Nicolas
Poras, Hervé
Teffo, Franck
Beslot, Fran?oise
Selkti, Mohamed
Tomas, Alain
Scalbert, Elizabeth
Bennejean, Caroline
Renard, Pierre
Fournié-Zaluski, Marie-Claude
Roques, Bernard-Pierre
We have previously reported the design of a lead compound 1a for the joint inhibition of neprilysin (NEP, EC 3.4.24.11), angiotensin converting enzyme (ACE, EC 3.4.15.1) and endothelin converting enzyme (ECE-1, EC 3.4.24.71), three metallopeptidases which are implicated in the regulation of fluid homeostasis and vascular tone. We report here the synthesis and biological activities of analogues derived from this lead with inhibitory potencies in the nanomolar range for the three enzymes. Compounds 8b and 15c are the most potent triple inhibitors described to date.
View MoreMeryer (Shanghai) Chemical Technology Co., Ltd.
website:http://www.meryer.com/cn/index/
Contact:+86-755-86170518
Address:Minhang,Shanghai, China
Hangzhou innopharma technology Co,.Ltd.(expird)
Contact:+86-13388601988
Address:Room845,lixin building, moganshan road, hangzhou, china
SHANXI XINTIANYUAN PHARMACEUTICAL CO., LTD.
website:http://www.tychemical.com
Contact:0086-358-3521713 3521715
Address:No. 1 Yintong Road, Shanxi Jiaocheng Economic Development Zone, Xiajiaying Town, Jiaocheng County, Lvliang City, Shanxi Province, China
Hefei EnliPharma Tecnology Co.,Ltd
Contact:0086-551-66399836
Address:Qing Cheng ShuiXiang Building 805, Mengcheng North Road , ShuangFeng Economic Development Zone Anhui HeFei
Hebei Tianxiang Biological & Pharmaceutical Co., Ltd
Contact:86-0312-6615158
Address:No 42 fazhan street qingyuan county
Doi:10.1016/S0040-4039(02)01723-9
(2002)Doi:10.1007/BF00472333
()Doi:10.1021/ic50036a005
(1966)Doi:10.1248/cpb.21.1005
(1973)Doi:10.3987/com-02-s(m)17
(2002)Doi:10.1021/ol026913a
(2003)